The roles of natriuretic peptides in pericardial fluid in patients with heart failure

Clinical Cardiology

Volumn 32, Issue 3, 2009, Pages 159-163

  Watanabe, Masazumi ^a   Kawaguchi, Satoru ^a   Nakahara, Hideki ^a   Hachimaru, Tsuyoshi ^a  

^a TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

Author keywords

Heart failure; Left ventricular function; Natriuretic peptide; Pericardial fluid

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

AORTA ANEURYSM; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; HEART ATRIUM SEPTUM DEFECT; HEART FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMMUNORADIOMETRIC ASSAY; MITRAL VALVE REPLACEMENT; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; HEART FAILURE; HUMANS; LEAST-SQUARES ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PERICARDIAL EFFUSION;

EID: 64349083782     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20306     Document Type: Article

References (17)

1. Moe GW, Grima EA, Wong NM, Howard RJ, Armstrong PW: Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. J Am Coll Cardiol 1996;27:720-727
2. Yoshimura M, Yasue H, Ogawa H: Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure. Can J Physiol Pharmacol 2001;79:730-735
3. Mebazaa A, Wetzel RC, Dodd-o JM, Redmond EM, Shah AM, et al.: Potential paracrine role of the pericardium in the regulation of cardiac function. Cardiovasc Res 1998;40:332-342
4. Klemola R, Tikkanen I, Vuolteenaho O, Toivonen L, Laine M: Plasma and pericardial fluid natriuretic peptide levels in postinfarction ventricular dysfunction. Eur J Heart Fail 2001;3(1): 21-26
5. Raymond RJ, Hinderliter AL, Willis PW, Palph D, Caldwell EJ, et al.: Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. Am J Coll Cardiol 2002;39: 1214-1219
6. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, et al.: Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heartfailure. Circulation 1991;84:1581-1588
7. Kuroski-de Bold ML, de Bold AJ: Stretch-secretion coupling in atrial cardiocytes: dissociation between atrial natriuretic factor release and mechanical activity. Hypertension 1991;18: III-169-III-178
8. Fujita M, Komeda M, Hasegawa K, Kihara Y, Nohara R, et al.: Pericardial fluid as a new material for clinical heart research. Int J Cardiol 2001;77:113-118
9. Tanaka T, Hasegawa K, Fujita M, Tamaki SI, Yamazato A, et al.: Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. J Am Coll Cardiol 1998;31(2):399-403
10. Tamamori M, Ito H, Hiroe M, Marumo F, Hata RI: Stimulation of collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic culture conditions and suppression of the effect by natriuretic peptides. Cell Biol Int 1997;21(3):175-180
11. Ogawa Y, Tamura N, Chusho H, Nakao K: Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can J Physiol Pharmacol 2001;79(8):723-729
12. Nishikawa N, Yamamoto K, Sakata Y, Mano T, Yoshida J, et al.: Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res 2003;57:766-774
13. Lai T, Fallon JT, Liu J, Mangion J, Gillam L, et al.: Reversibility and pathohistological basis of left ventricular remodeling in hibernating myocardium. Cardiovasc Pathol 2000;9:323-335
14. Xiongbin L, Jorg H, Frauke H, Richard S, Rudolf EL: Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 1995;77:750-758
15. Cao L, Gardner DG: Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 1995;25:227-234
16. Fujita M, Ikemoto M, Tanaka T, Tamaki S, Yamazato A, et al.: Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris. Angiogenesis 1998;2:105-108
17. Kubota T, Namiki A, Fukazawa M, Ishikawa M, Moroi M, et al.: Concentrations of hepatocyte growth factor, basic fibroblast growth factor, and vascular endothelial growth factor in pericardial fluid and plasma. Jpn Heart J 2004;45:989-998